Cladribine use for multiple sclerosis with autoimmune comorbidities: retrospective analysis of the French MS registry, case series, and therapeutic considerations

Vito A. G. Ricigliano, Ines Masmoudi, Marine Boudot de la Motte, Eric Manchon, Jérôme De Seze

Open source

DOI
10.1177/17562864261458568
Published
2026-06
Container
Therapeutic Advances in Neurological Disorders
Publisher
SAGE Publications
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/17562864261458568,
  title = {Cladribine use for multiple sclerosis with autoimmune comorbidities: retrospective analysis of the French MS registry, case series, and therapeutic considerations},
  author = {Vito A. G. Ricigliano and Ines Masmoudi and Marine Boudot de la Motte and Eric Manchon and Jérôme De Seze},
  year = {2026},
  journal = {Therapeutic Advances in Neurological Disorders},
  doi = {10.1177/17562864261458568},
  url = {https://doi.org/10.1177/17562864261458568}
}

RIS

TY  - JOUR
TI  - Cladribine use for multiple sclerosis with autoimmune comorbidities: retrospective analysis of the French MS registry, case series, and therapeutic considerations
AU  - Vito A. G. Ricigliano
AU  - Ines Masmoudi
AU  - Marine Boudot de la Motte
AU  - Eric Manchon
AU  - Jérôme De Seze
PY  - 2026
JO  - Therapeutic Advances in Neurological Disorders
DO  - 10.1177/17562864261458568
UR  - https://doi.org/10.1177/17562864261458568
ER  - 

APA

Ricigliano, V. A. G., Masmoudi, I., Motte, M. B. D. L., Manchon, E., & Seze, J. D. (2026). Cladribine use for multiple sclerosis with autoimmune comorbidities: retrospective analysis of the French MS registry, case series, and therapeutic considerations. Therapeutic Advances in Neurological Disorders. https://doi.org/10.1177/17562864261458568

Source records